Key Takeaways
- A treatment proposal is not yet an informed decision. Ask which records were reviewed, what remains uncertain and what could change after examination or repeat testing.
- Compare the recommended option with reasonable alternatives, including delaying or declining treatment when clinically appropriate. Shared decision making combines evidence and clinical experience with the patient’s goals and circumstances [1][2].
- Ask for outcomes that have a definition, denominator and time frame. “High success” is not interpretable until success and the relevant patient group are clear.
- Separate the treating clinician, hospital and facilitator. Verify who diagnoses, performs the procedure, obtains consent, provides after-hours care and receives payment.
- Make the complication plan before paying a non-refundable deposit: emergency capability, revision treatment, extra stay, cost responsibility and care after returning home all matter [3].
- Consent is a conversation, not a signature. Use a qualified interpreter and teach-back to check understanding [1][6].
Content
An overseas plan can arrive as a polished PDF: a treatment name, optimistic timeline, package price and a few testimonials. It may still leave the clinical decision almost untouched. The useful work begins when the patient can explain, in plain language, why this option was recommended, what else could be done, what might go wrong and who will help if the expected recovery does not happen.
Shared decision making is a collaboration in which evidence and clinical expertise meet the patient’s values, goals, preferences and real-life circumstances [2]. NICE recommends discussing the aims, risks, benefits and consequences of each option, including no treatment or no change, and checking what the person hopes to gain [1]. Distance, language, payment and travel add extra handoffs, but they do not reduce that standard.
1. What diagnosis is the plan actually treating?
Ask the named clinician—not only a coordinator—to state:
- the working or confirmed diagnosis;
- disease stage, severity or subtype when relevant;
- the reports, images, pathology or examinations supporting it;
- what has been reviewed directly and what was seen only in a summary;
- important missing or outdated information;
- alternative diagnoses still being considered.
“Records reviewed” is too vague. A surgeon may need the actual imaging series, an oncologist the pathology and biomarkers, and a neurologist the event history plus raw imaging or electrophysiology. Ask whether the hospital will repeat tests or re-review pathology after arrival and how a different result could change eligibility, timing, price or treatment.
Do not book a procedure solely from a marketing label or an unsigned translation. Keep the original report and clearly distinguish “suspected,” “probable” and “confirmed.” If symptoms are rapidly worsening or potentially emergent, seek local assessment rather than waiting for an overseas file review.
2. Why this option for this patient, now?
Ask the clinician to connect the recommendation to the patient’s specific anatomy, disease behavior, prior treatment, age, function, other illnesses, medicines and goals. Then ask:
- What problem is this intended to solve?
- Is the aim cure, longer control, symptom relief, diagnosis, function or appearance?
- Why is now the right time?
- What happens if we wait two weeks, two months or do nothing?
- Which factors make this patient a better or worse candidate?
- What finding would make you cancel or change the plan?
A plan built for the “average patient” can fail at the edges. Anticoagulation, kidney function, frailty, prior radiation, infection, pregnancy or limited caregiver support may change both risk and feasibility. Ask whether optimization or prehabilitation could improve the balance before treatment.
3. What are the real alternatives?
Do not accept a comparison between the proposed treatment and no care unless those truly are the only options. Ask about:
- observation or active surveillance;
- medicines, rehabilitation or another non-procedural approach;
- a different operation, device, drug or radiation technique;
- treatment at home or at another centre;
- palliative/supportive care;
- no treatment or a later decision.
For each reasonable option, compare the same outcomes and time horizon. The American College of Surgeons advises patients to ask why an operation is needed, whether other treatments are available, what is likely without it and how surgery is expected to improve health or quality of life [4][5]. A second opinion is especially useful when the diagnosis is uncertain, the treatment is irreversible, risks are substantial, the evidence is contested or the proposed approach is available only through one seller.
Ask whether the clinician has a financial, referral or ownership relationship with the recommended facility, device, laboratory or facilitator. A disclosed interest does not automatically invalidate advice, but it belongs in the decision.
4. What does “success” mean, and whose results are these?
Turn every percentage into a complete sentence. Ask:
- What exact outcome is measured—technical completion, symptom improvement, remission, survival, function or patient satisfaction?
- How many patients were included, and how many experienced the outcome?
- Over what period?
- Were patients similar in diagnosis, severity, age and prior treatment?
- Is the figure from published evidence, a registry, this hospital or this clinician?
- How were people lost to follow-up handled?
- Does the number include conversions, revisions, readmissions or repeat procedures?
Relative improvements can look large while the absolute difference is small. Ask for both when possible. A result from carefully selected low-risk patients should not be applied to a high-risk individual without explanation. Testimonials describe individual experiences; they are not a denominator.
If local outcome data cannot be shared, ask what quality measures the service actually tracks: infection, reoperation, unexpected ICU admission, readmission, mortality, functional outcomes and patient-reported outcomes. “We have never had a complication” is not credible for an invasive treatment.
5. Which harms matter most to this patient?
Request a patient-specific discussion of:
- common short-term effects;
- uncommon but serious complications;
- effects on mobility, cognition, fertility, continence, swallowing, speech or work;
- chance of transfusion, ICU care, conversion to a more extensive procedure or permanent device;
- long-term failure, recurrence, revision or retreatment;
- risks caused by the patient’s diseases and medicines;
- risks of travel, immobility and early return.
The clinician should explain what can be done to prevent, detect and treat each important harm. ACS principles describe informed consent as more than a legal form and call for fair discussion of the illness, proposed procedure, mortality/morbidity, common complications, alternatives and consequences of no treatment [5].
Ask how risk estimates were individualized. A calculator can support discussion but cannot capture every factor, and a generic percentage should not be presented as a personal guarantee. Also ask which outcome the patient would consider unacceptable even if the procedure were technically successful.
6. Who is responsible at each step?
Write names and roles beside the plan:
- clinician who reviewed the records and made the recommendation;
- person performing the procedure or prescribing treatment;
- anaesthetist and other critical specialists;
- consultant available if the plan changes;
- hospital/facility where each part occurs;
- professional responsible overnight and at weekends;
- person who can authorize urgent changes;
- clinician receiving follow-up after return.
Verify professional registration and the correct specialty through the relevant regulator or hospital, not through a logo in a brochure. Ask how often the clinician and team perform this exact treatment in patients like this one. For a procedure, confirm anaesthesia, imaging, pathology, pharmacy, blood bank, infection control, intensive care and emergency transfer capabilities as relevant.
A facilitator may translate, schedule and coordinate payment; that does not make the facilitator the treating clinician. Ask who employs the coordinator, who pays commission, who holds the medical record and where a complaint is directed.
7. What exactly will happen from arrival to return?
Request a dated pathway rather than “about ten days”:
- arrival and pre-treatment assessment;
- tests or pathology review still required;
- decision point when the plan becomes final;
- treatment dates and named site;
- expected ward, ICU or outpatient course;
- discharge criteria;
- accommodation and daily review after discharge;
- clearance criteria for the actual return route;
- remote and home-clinician follow-up.
Ask what happens if the patient arrives unfit, the diagnosis changes, equipment is unavailable, recovery is slow or the return flight must move. A preliminary plan should explicitly show its conditions rather than disguising them as certainty.
CDC notes that procedure risk is only part of medical travel: infection, communication, postoperative activity, long travel, continuity and the cost of complications also need planning [3]. Do not combine recovery with sightseeing until the treating team has cleared the specific activities.
8. What is included, excluded and financially open-ended?
Match the cost sheet to the clinical pathway. Separate professional fees, facility fees, anaesthesia, tests, imaging, pathology, medicines, implants, blood, ICU, room, interpretation, rehabilitation and follow-up. Then ask:
- Which items are estimates rather than fixed prices?
- What clinical findings trigger an added procedure or device?
- Who approves an extra charge when the patient is sedated or incapacitated?
- Are complication treatment, revision, extra nights and emergency transfer included?
- What is refundable if eligibility changes after arrival?
- Who receives each payment, in which currency, with what receipt?
- What does home insurance or travel insurance exclude?
The cheapest package can become the most expensive pathway when essential services sit outside it. Never let a deposit deadline replace time for informed decision making.
9. How will complications and follow-up cross the border?
Before accepting, identify a local clinician willing to participate after return and confirm what they can realistically provide. Ask the overseas team:
- Which warning signs require local emergency care rather than a message?
- Is after-hours advice available, and in which language and time zone?
- Who reviews wounds, laboratory tests, imaging and rehabilitation progress?
- How quickly will the operative note, pathology, implant/device details, images and discharge summary be released?
- Who pays if a complication needs treatment at home or return abroad?
- What is the escalation route if remote advice is delayed?
CDC recommends arranging local follow-up and financing before travel and obtaining a complete set of records to support continuity [3]. A messaging account is not an emergency service, and “lifetime follow-up” is meaningless without named clinicians, response times and clinical scope.
10. Can the patient explain the choice back?
Consent obtained through unfamiliar jargon or a family member’s improvised translation is fragile. Arrange a qualified interpreter who is not selling the treatment. Ask for translated information early enough to read it, and ensure the clinician—not only administrative staff—answers clinical questions.
Use teach-back: “To make sure this was explained clearly, I’ll describe what I think the options, main benefits, serious risks and recovery plan are.” NICE treats teach-back as a way to check how well information was explained, not a test of the patient [1]. The Joint Commission likewise emphasizes that informed consent requires understanding of the nature, risks, benefits and alternatives, not merely a signature [6].
Pause if the plan changes materially after consent. A different procedure, implant, clinician, site or risk profile requires a new discussion. Pressure to pay immediately, refusal to name the operator, guaranteed outcomes, dismissal of alternatives, missing complication plans or instructions to conceal treatment from the home doctor are reasons to stop and independently verify.
FAQ
1. Is accreditation enough to accept a treatment plan?
No. Accreditation can inform facility review, but it does not confirm that the diagnosis, clinician, procedure and follow-up plan are right for this patient.
2. Should every patient get a second opinion?
Not necessarily. It is particularly valuable when the diagnosis is uncertain, treatment is irreversible or high risk, reasonable clinicians may disagree, or the proposal comes from a single commercial channel.
3. How should a “95% success rate” be checked?
Ask what success means, the denominator, follow-up period, patient selection, data source and whether complications, revisions and loss to follow-up were included.
4. Can a coordinator answer consent questions?
A coordinator can organize information, but the responsible clinician should explain the diagnosis, recommendation, alternatives, patient-specific risks and consequences of declining treatment.
5. What should happen if the plan changes after arrival?
Ask for the new evidence, alternatives, risks, timing and cost in writing; use an interpreter; allow time for questions; and complete a new consent discussion before non-emergency treatment proceeds.
Sources
- National Institute for Health and Care Excellence — Shared Decision Making Recommendations
- Agency for Healthcare Research and Quality — About Shared Decision Making
- U.S. Centers for Disease Control and Prevention — Medical Tourism, Yellow Book
- American College of Surgeons — Questions to Ask Before Having an Operation
- American College of Surgeons — Statement on Principles
- The Joint Commission — Informed Consent: More Than Getting a Signature